BILB-1941

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C34H34N4O4
Molecular Weight	562.6582
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1C2=C(C=CC(=C2)C(=O)NC3(CCC3)C(=O)NC4=CC=C(\C=C\C(O)=O)C=C4)C(C5CCCC5)=C1C6=CC=CC=N6

InChI

InChIKey=JBSNALXXNTWUEC-SFQUDFHCSA-N

InChI=1S/C34H34N4O4/c1-38-28-21-24(13-16-26(28)30(23-7-2-3-8-23)31(38)27-9-4-5-20-35-27)32(41)37-34(18-6-19-34)33(42)36-25-14-10-22(11-15-25)12-17-29(39)40/h4-5,9-17,20-21,23H,2-3,6-8,18-19H2,1H3,(H,36,42)(H,37,41)(H,39,40)/b17-12+

HIDE SMILES / InChI

Approval Year

Name

Type

Language

BILB-1941

Common Name

English

(2E)-3-(4-(((1-(((3-CYCLOPENTYL-1-METHYL-2-(2-PYRIDINYL)-1H-INDOL-6-YL)CARBONYL)AMINO)CYCLOBUTYL)CARBONYL)AMINO)PHENYL)-2-PROPENOIC ACID

Systematic Name

English

N-(1-(((4-((E)-2-(CARBOXY)ETHENYL)PHENYL)AMINO)CARBONYL)CYCLOBUTYL)-3-CYCLOPENTYL-1-METHYL-2-(PYRIDIN-2-YL)INDOLE-6-CARBOXAMIDE

Systematic Name

English

2-PROPENOIC ACID, 3-(4-(((1-(((3-CYCLOPENTYL-1-METHYL-2-(2-PYRIDINYL)-1H-INDOL-6-YL)CARBONYL)AMINO)CYCLOBUTYL)CARBONYL)AMINO)PHENYL)-, (2E)-

Systematic Name

English

BILB-1941ZW

Code

English

Code System Code Type Description

CAS

494856-61-0

Created by admin on Sat Dec 16 11:38:20 GMT 2023 , Edited by admin on Sat Dec 16 11:38:20 GMT 2023

PRIMARY

FDA UNII

3WV68DY85W

Created by admin on Sat Dec 16 11:38:20 GMT 2023 , Edited by admin on Sat Dec 16 11:38:20 GMT 2023

PRIMARY

PUBCHEM

56949326

Created by admin on Sat Dec 16 11:38:20 GMT 2023 , Edited by admin on Sat Dec 16 11:38:20 GMT 2023

PRIMARY

CLINICAL_TRIALS.GOV

BILB-1941

Created by admin on Sat Dec 16 11:38:20 GMT 2023 , Edited by admin on Sat Dec 16 11:38:20 GMT 2023

PRIMARY

Official Title: A Multinational Randomised, Double-blind, Placebo Controlled Study to Evaluate the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW Oral Solution Administered Q8H for Five Days to Patients With Chronic Hepatitis C Genotype 1 Virus Infection.Purpose: To assess the antiviral effect, safety and pharmacokinetics of rising doses of 10 mg, 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 150 mg, 200 mg, 300 mg, 450 mg, 650 mg, 900 mg oral BILB 1941 ZW administered Q8H in a polyethyleneglycol 400 (PEG 400): distilled water: Tromethamine (TRIS) drinking solution for five days to patients with chronic HCV genotype 1 infection.

ACTIVE MOIETY


					3WV68DY85W

BILB-1941